- £202.54m
- £155.41m
- $649.89m
- 60
- 99
- 53
- 84
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 343 | 406 | 596 | 686 | 650 |
Cost of Revenue | |||||
Gross Profit | 64.6 | 134 | 212 | 247 | 157 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 319 | 318 | 418 | 453 | 555 |
Operating Profit | 24.2 | 87.6 | 179 | 233 | 94.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.2 | 75.8 | 185 | 220 | 114 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.38 | 55 | 132 | 167 | 86.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 10.6 | 43.3 | 100 | 154 | 82.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.6 | 43.3 | 100 | 154 | 82.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.052 | 0.17 | 0.386 | 0.444 | 0.281 |
Dividends per Share |